Dabur Q1 FY27: Double-Digit Growth, Premiumization Tailwinds, and a Watchful Eye on Inflation

Dabur India Limited began FY27 with a strong first quarter, even as the operating backdrop remained messy. For the quarter ended June 30, 2026, the company reported consolidated revenue from operations of INR 3,764.4 crore, up 10.6% year-on-year. Profitability also improved faster than revenue. Consolidated operating profit rose 11.0% to INR 741.4 crore, while reported net profit increased 15.0% to INR 590.9 crore.

Management attributed the performance to broad-based growth across India and international markets, supported by premiumization, innovation, and disciplined cost management. The quarter was not without disruptions. The company highlighted war-led disruptions in the Middle East, inflationary pressures, and unseasonal rainfall in April and early May that hurt summer-centric categories such as glucose and beverages.

Growth drivers: India momentum led by HPC and Foods

In India, FMCG revenue grew 9.5% year-on-year, backed by 5% volume growth, indicating that demand was not purely price-led. Within domestic operations, Home and Personal Care (HPC) maintained strong momentum with 12.3% year-on-year growth. In the investor presentation, HPC contributed 55% of domestic revenue and reported revenue of INR 1,385 crore.

Hair care continued to be a key engine. Management stated that hair oils grew in high teens year-on-year, with both perfumed and coconut oils growing in double digits. The company also said it gained 102 basis points of market share in hair oils. Shampoos delivered strong double-digit growth, with Vatika launching the Bio-Infusions range, described as India’s first no-added salt shampoo range.

Oral care delivered near double-digit growth, led by Dabur Red, Meswak, and the Dabur Herbal range. Lal Dant Manjan also posted double-digit growth, and management pointed to a structural tailwind: consumer preferences shifting toward ayurvedic, herbal, and natural solutions, with the herbal segment outperforming the non-herbal segment by 550 basis points.

The Foods and Beverages segment delivered 7.2% year-on-year growth in the presentation, with domestic revenue of INR 528 crore and 21% contribution to domestic revenue. Within this, Foods including Badshah grew strongly. Management stated that Foods grew around 30% and Badshah delivered volume-led double-digit growth.

Beverages faced a weather impact early in the quarter, but management said the business recovered in May and June, with mid-teens growth. Premium beverage lines were a standout. Management stated that active juices grew by over 40% and coconut water grew by over 70% in the quarter, alongside market share gains of around 600 basis points in active juices and 344 basis points in coconut water.

Healthcare steady, seasonality visible in select categories

The Healthcare segment recorded 5.5% year-on-year growth in the presentation, with domestic revenue of INR 623 crore and 24% contribution to domestic revenue. The internal mix was uneven. Health supplements grew in low single digits, with Honey delivering high single-digit growth and management citing a 150 basis points market share gain. Premium honey variants such as Sundarbans and Organic Honey were called out as growing well.

Seasonality played a role in glucose. Unseasonal rainfall in April and early May disrupted demand. In the concall, management said glucose bounced back in May and June, delivering mid-teens and high-teens growth. They also clarified glucose is largely a rural consumption category used for instant energy, and did not indicate a structural demand concern within the call.

Digestives delivered stronger momentum. Pudin Hara grew in double digits, Hajmola posted near double-digit growth supported by a packaging refresh, and Isabgol delivered strong double-digit growth. In OTC and Ethicals, Honitus grew 25%, supported by targeted media campaigns.

International business: strong growth with MENA volatility

International business growth remained resilient despite war-related disruption in the Middle East. Consolidated international revenue was INR 1,006 crore in the presentation, contributing 27% to consolidated revenue, with 15.5% year-on-year growth in INR terms.

The presentation showed strong growth across several markets, including Bangladesh, Turkey, UK, SSA, Nigeria, and Egypt. However, the MENA region showed a more volatile picture, with INR growth of 5.2% but constant currency growth of negative 5.4%, reflecting underlying softness that management linked to geopolitical volatility.

Profitability: margins edged up despite inflation

Dabur reported margin expansion despite elevated inflation. Consolidated operating margin improved 10 basis points to 19.7%, while EBITDA margin including other income expanded 50 basis points to 24.3%. Net profit margin improved 60 basis points to 15.7%.

The company attributed margin resilience to a combination of premiumization, productivity improvement initiatives, and disciplined cost management. Management was also candid that inflation remains a live variable, especially crude-linked inflation influenced by geopolitical events.

Financial snapshot (Consolidated)

Strategic focus: premiumization, new age channels, and D2C options

Management reiterated that premiumization continues to be a major lever. Beyond premium beverages, premium honey variants were also highlighted. The company also noted robust double-digit growth in new age channels such as e-commerce and modern trade.

A key strategic discussion in the concall was around D2C acquisitions. Management indicated that INR 500 crore has been earmarked for D2C acquisitions. The company described a two-step approach: entering via minority stakes, working with founders to improve profitability, and then increasing to a majority stake once the business turns profitable.

Management provided a time horizon of around three years to potentially acquire one or two sizable companies, while clarifying that outcomes depend on negotiations and bid processes.

In innovation, management called out Siens, a nutraceutical brand positioned as a D2C healthcare play. The CEO stated Siens grew three times during the quarter and is expected to exit the year with roughly INR 50 crore ARR.

What management said to watch going forward

Management stated confidence in delivering sequential acceleration in revenue growth, but also emphasized close monitoring of geopolitical developments in the Middle East. It maintained its target of double-digit consolidated revenue growth for the full year.

At the same time, management was cautious on volume expectations, stating that volume is unlikely to be double-digit given inflation and the need to pass costs to consumers. It also linked the margin outlook to how crude-linked inflation evolves, which is tied to the geopolitical environment.

Takeaways

Dabur’s Q1 FY27 results reflect a business delivering steady execution across a complex operating environment. HPC continued to lead domestic growth, Foods including Badshah remained strong, and premium beverages showed outsized momentum. International performance was broadly healthy, but MENA remains a region to watch due to geopolitical volatility.

The quarter also underlined Dabur’s strategic intent. Management highlighted premiumization and innovation, a growing role for e-commerce, and an active search for D2C acquisition opportunities with a stated three-year horizon. The next few quarters are likely to be shaped by two external variables the company itself emphasized: inflation and geopolitics, alongside the pace of demand recovery in weather-impacted categories.